Tech Company Financing Transactions
Ikano Therapeutics Funding Round
On 3/2/2009, Ikano Therapeutics announced $9 million in Series B funding from SV Health Investors.
Transaction Overview
Company Name
Announced On
3/2/2009
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series B
Investors
SV Health Investors (Michael Ross)
Proceeds Purpose
These funds will complete ITI's transformation into a Phase 3 company and advance ITI-111's potential as an important new treatment for patients with epilepsy.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
250 Pehle Avenue 310
Saddle Brook, NJ 07663
USA
Saddle Brook, NJ 07663
USA
Phone
Website
Email Address
Overview
Ikano Therapeutics Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative specialty therapeutics, with an emphasis on drugs in areas for which there is proven, unsatisfied medical and patient need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Young
Chief Financial Officer
Pat Fabbio
Chief Medical Officer
Jeffery Edelson
VP - Bus. Development
Kathleen Boziwick
Browse more venture capital transactions:
Prev: 3/2/2009: Siimpel venture capital transaction
Next: 3/2/2009: NeoSystems venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs